Related Experiment Video

Updated: Aug 11, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Low-density lipoprotein size and cardiovascular prevention

Manfredi Rizzo1, Kaspar Berneis

  • 1Department of Clinical Medicine and Emerging Diseases, University of Palermo, Italy. mrizzo@unipa.it

European Journal of Internal Medicine
|February 24, 2006
PubMed

Insights

Low-density lipoprotein (LDL) particle size is a key cardiovascular risk factor. Measuring LDL size is recommended for patients at high risk of cardiovascular diseases to guide preventative therapies.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Preventive Cardiology

Background:

  • Low-density lipoprotein (LDL) size is increasingly recognized as a significant predictor of cardiovascular events and coronary artery disease progression.
  • The predominance of small, dense LDL particles is an established cardiovascular risk factor, according to the National Cholesterol Education Program Adult Treatment Panel III.
  • However, debate exists regarding the independent value of LDL subclass measurements beyond standard risk factors.

Purpose of the Study:

  • To evaluate the clinical utility of LDL particle size measurement in cardiovascular risk assessment.
  • To determine the optimal patient populations for LDL size testing in cardiovascular prevention strategies.

Main Methods:

  • Review of existing literature and clinical guidelines on LDL particle size and cardiovascular risk.
  • Analysis of studies investigating the independent predictive value of LDL subclasses.
  • Discussion of therapeutic implications of targeting specific LDL subspecies.

Main Results:

  • LDL size is an important, though debated, predictor of cardiovascular events.
  • Small, dense LDL is an emerging risk factor, but its independent contribution is questioned.
  • Therapeutic modulation of LDL subspecies can significantly reduce cardiovascular event risk.

Conclusions:

  • LDL size measurement should be considered for cardiovascular risk assessment.
  • Expanded LDL size measurement is recommended for patients identified as high-risk for cardiovascular diseases.
  • Targeting specific LDL subspecies offers therapeutic benefits in cardiovascular event reduction.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...